Status:
COMPLETED
Bone Morphogenetic Protein-2 In Grade II Furcation Defects.
Lead Sponsor:
SVS Institute of Dental Sciences
Conditions:
Periodontitis
Eligibility:
All Genders
20-55 years
Phase:
NA
Brief Summary
The present study evaluated clinically and radiographically the regenerative potential of rhBMP-2 in absorbable sponge and PRF in Grade II furcation.
Detailed Description
44 subjects were enrolled in the study. PPD, CAL, plaque index and gingival index were recorded and the evaluation of bone fill was performed after 6 months by using ImageJ® software. After 6 months, ...
Eligibility Criteria
Inclusion
- Systemically healthy male and female patients of age group 20-55 yrs
- grade II furcation involvement and probing pocket depth of ≥5mm
Exclusion
- Medically compromised patients
- subjects who underwent radiotherapy or chemotherapy in the past 12 months
- patients having uncontrolled periodontal disease and
- subjects smoking ≥10 cigarettes per day were excluded
Key Trial Info
Start Date :
December 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 10 2019
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04372420
Start Date
December 5 2017
End Date
October 10 2019
Last Update
May 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RV Chandra
Hyderabad, Telangana, India, 509002